Intarcia Therapeutics

Intarcia Therapeutics is an American biotechnology firm specialized in developing treatments to chronic diseases. The company created a medicine delivery system called Medici. It also filed for FDA approval for a type 2 diabetes drug and has several drugs in the discovery and preclinical stages. Intarcia is headquartered in Boston, Massachusetts.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
  • Combo news

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
$  Share Price

Investors

GGV CapitalGGV Capital
Horizon Technology FinanceHorizon Technology Finance
Greenspring AssociatesGreenspring Associates
RA Capital ManagementRA Capital Management
FidelityFidelity

News related to Intarcia Therapeutics

Intarcia TherapeuticsIntarcia Therapeutics • 12 Oct 2021

i2O Therapeutics Announces the Appointment of Kurt C. Graves as ...

Over the last 10 years Mr. Graves has provided leadership to several innovative biotech companies as Chairman, President and CEO of Intarcia Therapeutics, ...

https://www.benzinga.com/pressreleases/21/10/b23342064/i2o-therapeutics-announces-the-appointment-of-kurt-c-graves-as-executive-chairman
Intarcia TherapeuticsIntarcia Therapeutics • 20 Aug 2021

Global Therapeutic Wearable Medical Devices Market Growth, Size ...

Aug 19, 2021 (The Expresswire) -- Global “Therapeutic Wearable Medical Devices Market" Analysis 2021-2027: Portable devices that use modern science and...

https://www.marketwatch.com/press-release/global-therapeutic-wearable-medical-devices-market-growth-size-revenue-2021-by-competitive-landscape-type-application-overview-with-detailed-analysis-risk-assessment-industry-forecast-value-and-share-till-2027-2021-08-19
Intarcia TherapeuticsIntarcia Therapeutics • 11 Aug 2021

Smart Implantable Pumps Market | Growth Insights, Share with ...

Abbott; Intarcia Therapeutics, Inc. Medtronic; FLOWONIX MEDICAL INC. Cognos Therapeutics, Inc. Rising Emphasis on Data Logging to Stoke Demand for ...

https://www.marketwatch.com/press-release/Smart-Implantable-Pumps-Market-Growth-Insights-Share-with-Global-Forecast-To-2026-2021-08-10
More (5)

Intarcia Therapeutics Twitter